Delivery Order HHSD200200824959I-HHSD2002008249590011

This federal contract, valued at $131,992.00, was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit limited liability company that manufactures goods. The contract is for the delivery of "WET VAX SMALL POX" and was awarded on a firm fixed-price basis on May 1, 2019, with a completion date of August 31, 2019. The contract does not have a set-aside designation....

The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Emergent Product Development Gaithersburg Inc. a firm fixed price contract valued at $804.9 million on August 30, 2019, for the manufacture and delivery of ACAM2000, a live vaccinia smallpox vaccine. The contract, which extends through August 29, 2029, supports the federal government's medical countermeasures stockpiling and pandemic preparedness initiatives. Work will be...

The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order valued at $2,825.20 to Emergent Biodefense Operations Lansing LLC for BioThrax vaccine, with an ultimate completion date of April 15, 2026. The place of performance is Atlanta, Georgia. This purchase order represents a civilian healthcare procurement with no set-aside designation and follows the Firm Fixed Price pricing model, indicating a predetermined cost structure for the vaccine...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for the WETVAX 2021 project. The contract has a potential value of $141,400.00 and a completion date of August 31, 2021. The contract does not have a set-aside designation. Emergent Biodefense Operations Lansing LLC is the prime contractor for this award, which is likely related to the agency's...

<p>This is a firm fixed-price delivery order contract for $838,800.00 awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Biologics, LLC, a foreign-owned for-profit organization, to provide smallpox diluent. The contract has an ultimate completion date of July 6, 2017 and was awarded on May 18, 2016. There is no set-aside designation mentioned for this contract.</p>

This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for WETVAX POTENCY TESTING. The contract has a potential value of $136,612.00 and is a Firm Fixed Price Purchase Order. The place of performance is Canton, MA 02021, USA. The contract does not have a set-aside designation. As the awardee, Emergent Biodefense Operations Lansing LLC is a for-profit...

This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...

This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...

This is a $30,559,760.00 cost-plus-fixed-fee delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for the development of the MAPP biopharmaceutical Viral Hemorrhagic Fever (VHF) Medical Countermeasure (MCM) platform. This work is being performed under the Centers for Innovation in...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order to the University of Massachusetts Biologic Labs, doing business as Massbiologics, to provide 25 doses of EDAT 160,000IU. The contract has a potential value of $125,000.00 and a completion date of September 20, 2023. The University of Massachusetts is the prime contractor, and there are no set-aside designations mentioned. The CDC is the primary customer for this...